Jessen, H., Hoyer, N.
, Prior, T. S., Frederiksen, P., Rønnow, S. R., Karsdal, M. A., Leeming, D. J.
, Bendstrup, E., Sand, J. M. B. & Shaker, S. B. (2021).
Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis.
BMC Pulmonary Medicine,
21, Article 382.
https://doi.org/10.1186/s12890-021-01684-3
Jessen, H., Hoyer, N.
, Prior, T. S., Frederiksen, P., Karsdal, M. A., Leeming, D. J.
, Bendstrup, E., Sand, J. M. B. & Shaker, S. B. (2021).
Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis.
Respiratory Research,
22(1), Article 205.
https://doi.org/10.1186/s12931-021-01801-0
Kalluri, M., Luppi, F., Vancheri, A., Vancheri, C., Balestro, E., Varone, F., Mogulkoc, N., Cacopardo, G., Bargagli, E., Renzoni, E., Torrisi, S., Calvello, M., Libra, A., Pavone, M., Bonella, F., Cottin, V., Valenzuela, C., Wijsenbeek, M.
& Bendstrup, E. (2021).
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? European Respiratory Review,
30(160), Article 210026.
https://doi.org/10.1183/16000617.0026-2021
Kølner-Augustson, L., Prior, T. S., Skivild, V., Aalestrup, A.
& Bendstrup, E. (2021).
Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment.
European Clinical Respiratory Journal,
8(1), Article 1853658.
https://doi.org/10.1080/20018525.2020.1853658
Kronborg-White, S., Sritharan, S. S., Madsen, L. B., Folkersen, B., Voldby, N.
, Poletti, V., Rasmussen, T. R. & Bendstrup, E. (2021).
Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures.
Journal of Thoracic Disease,
13(3), 1455-1465.
https://doi.org/10.21037/jtd-20-2431
Lamb, D., De Sousa, D., Quast, K., Fundel-Clemens, K., Erjefält, J. S., Sandén, C.
, Hoffmann, H. J., Kästle, M., Schmid, R., Menden, K. & Delic, D. (2021).
RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.
Respiratory Research,
22, Article 158.
https://doi.org/10.1186/s12931-021-01743-7
Maher, T. M.
, Bendstrup, E., Dron, L., Langley, J., Smith, G., Khalid, J. M., Patel, H. & Kreuter, M. (2021).
Global incidence and prevalence of idiopathic pulmonary fibrosis.
Respiratory Research,
22(1), Article 197.
https://doi.org/10.1186/s12931-021-01791-z
Meier, D.
, Lodberg, A., Gvozdenovic, A., Pellegrini, G., Neklyudova, O., Born, W., Fuchs, B.
, Eijken, M. & M Botter, S. (2021).
Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma.
Cancer Medicine,
10(1), 286-296.
https://doi.org/10.1002/cam4.3581
Møller, J., Altraja, A.
, Rasmussen, F., Madsen, L. B. & Bendstrup, E. (2021).
International multidisciplinary team discussions on the diagnosis of idiopathic non-specific interstitial pneumonia and the development of connective tissue disease.
European Clinical Respiratory Journal,
8(1), Article 1933878.
https://doi.org/10.1080/20018525.2021.1933878
Paoletti, G., DiBona, D., Chu, D. K., Firinu, D., Heffler, E., Agache, I., Jutel, M., Klimek, L., Pfaar, O., Mösges, R., Dunn Galvin, A., Genuneit, J.
, Hoffmann, H. J. & Canonica, G. W. (2021).
Allergen immunotherapy: The growing role of observational and randomized trial “Real-World Evidence”.
Allergy: European Journal of Allergy and Clinical Immunology,
76(9), 2663-2672.
https://doi.org/10.1111/all.14773
Piciucchi, S., Ravaglia, C., Vizzuso, A., Bertocco, M.
& Poletti, V. (2021).
Reversibility of venous dilatation and parenchymal changes density in Sars-Cov-2 pneumonia: toward the definition of a peculiar pattern.
Pulmonology,
27(4), 353-357.
https://doi.org/10.1016/j.pulmoe.2020.10.010
Pietersen, P. I.
, Jørgensen, R., Graumann, O., Konge, L.
, Skaarup, S. H., Lawaetz Schultz, H. H.
& Laursen, C. B. (2021).
Training Thoracic Ultrasound Skills: A Randomized Controlled Trial of Simulation-Based Training versus Training on Healthy Volunteers.
Respiration,
100(1), 34-43.
https://doi.org/10.1159/000509298
Poletti, V., Vancheri, C., Albera, C., Harari, S., Pesci, A., Metella, R. R., Campolo, B., Crespi, G., Rizzoli, S. & the FIBRONET study group (2021).
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study.
Respiratory Research,
22(1), Article 66.
https://doi.org/10.1186/s12931-021-01643-w
Polke, M., Kondoh, Y., Wijsenbeek, M., Cottin, V., Walsh, S. L. F., Collard, H. R., Chaudhuri, N., Avdeev, S., Behr, J., Calligaro, G., Corte, T. J., Flaherty, K., Funke-Chambour, M., Kolb, M., Krisam, J., Maher, T. M., Molina Molina, M., Morais, A., Moor, C. C. ... Kreuter, M. (2021).
Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.
Frontiers in medicine,
8, Article 699644.
https://doi.org/10.3389/fmed.2021.699644
Prior, T. S., Hoyer, N., Hilberg, O., Shaker, S. B., Davidsen, J. R.
, Rasmussen, F. & Bendstrup, E. (2021).
Clusters of comorbidities in idiopathic pulmonary fibrosis.
Respiratory Medicine,
185, Article 106490.
https://doi.org/10.1016/j.rmed.2021.106490
Prior, T. S., Hoyer, N., Shaker, S. B., Davidsen, J. R.
, Hilberg, O., Patel, H.
& Bendstrup, E. (2021).
Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire.
Respiratory Research,
22, Article 259.
https://doi.org/10.1186/s12931-021-01853-2